AstroNova (ALOT) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
14 Apr, 2026Executive summary
Fiscal 2026 marked a foundational reset, with H2 showing early benefits from operational and strategic changes, momentum in Product ID turnaround, and strong Aerospace performance.
Focused on stabilizing operations, improving cash generation, reducing debt, and raising accountability.
Board is evaluating strategic alternatives, including potential sale, merger, or continued organic growth, to unlock shareholder value.
Product Identification segment showed commercial momentum, while Aerospace benefited from strong ToughWriter adoption.
Total orders in Q4 increased 6.5% to $41.1 million; operating cash flow improved significantly year-over-year.
Financial highlights
FY2026 consolidated revenue was $150.5 million, nearly flat year-over-year from $151.3 million; Q4 revenue was $37.5 million, up $0.2 million year-over-year.
Q4 gross profit was $11.3 million (gross margin 30.2%), with non-GAAP gross profit at $11.9 million (31.7% margin); full-year gross margin was 31.6%.
Adjusted EBITDA for Q4 was $3.3 million (8.8% margin); full-year Adjusted EBITDA was $12.7 million (8.4% margin).
Q4 net loss was $1.1 million (GAAP), or $0.15 per share; non-GAAP net loss was $0.3 million; full-year net loss was $2.4 million.
Cash from operations in Q4 was $3.7 million; full-year cash from operations was $11.7 million.
Outlook and guidance
Fiscal 2027 expected to deliver mid-single digit revenue growth and expanded adjusted EBITDA margin.
Aerospace segment to benefit from rising aircraft production, favorable mix, and expiration of a major royalty obligation in Q3, adding ~$2 million to annualized gross profit starting Q4.
Product ID segment focused on converting pipeline into consistent revenue growth and improving profitability.
Latest events from AstroNova
- Recurring revenue, acquisitions, and innovation drive growth and margin expansion.ALOT
Sidoti Micro-Cap Virtual Conference2 Feb 2026 - Q1 revenue down 7%, net income up, and MTEX NS acquisition boosts future growth.ALOT
Q1 20251 Feb 2026 - Q2 revenue up 14.1% with margin gains; MTEX integration impacts near-term profitability.ALOT
Q2 202520 Jan 2026 - Accelerating growth through innovation, acquisitions, and operational excellence.ALOT
2024 Southwest IDEAS Conference13 Jan 2026 - Revenue up 7.7% but net income and margins fell sharply amid MTEX integration challenges.ALOT
Q3 202511 Jan 2026 - Q3 FY26 revenue up 8.5% sequentially, margins and cash flow improved, outlook reaffirmed.ALOT
Q3 202612 Dec 2025 - Board recommends its director slate, annual say-on-pay, and auditor ratification amid proxy contest.ALOT
Proxy Filing1 Dec 2025 - Board recommends its nominees and strategic direction amid proxy contest and operational changes.ALOT
Proxy Filing1 Dec 2025 - Six director nominees proposed, board rejects dissident slate to protect strategic direction.ALOT
Proxy Filing1 Dec 2025